Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Laura Soucek

Showing results (11-20 of 71) with videos related to

Pageof 8
Sort By:
Molecular & Cellular Oncology|September 19, 2019
Finding MYCureMarie-Eve Beaulieu, Laura Soucek
Cancer Drug Resistance (Alhambra, Calif.)|May 18, 2022
MYC inhibitors in multiple myelomaSandra Martínez-Martín, Laura Soucek
Cold Spring Harbor Protocols|March 4, 2015
Tamoxifen administration to miceJonathan Whitfield, Trevor Littlewood, Laura Soucek
Cells|April 26, 2020
Structural and Biophysical Insights into the Function of the Intrinsically Disordered Myc OncoproteinMarie-Eve Beaulieu, Francisco Castillo, Laura Soucek
Oncoscience|August 5, 2016
Ibrutinib repurposing: from B-cell malignancies to solid tumorsDaniel Massó-Vallés, Toni Jauset, Laura Soucek
Translational Lung Cancer Research|January 11, 2024
eIF4A dependency: the hidden key to unlock KRAS mutant non-small cell lung cancer's vulnerabilitySilvia Casacuberta-Serra, Iñigo Gonzalez-Larreategui, Laura Soucek
Frontiers in Cell and Developmental Biology|March 11, 2017
Strategies to Inhibit Myc and Their Clinical ApplicabilityJonathan R Whitfield, Marie-Eve Beaulieu, Laura Soucek
Expert Opinion on Therapeutic Targets|February 1, 2020
MYC, MYCL, and MYCN as therapeutic targets in lung cancerDaniel Massó-Vallés, Marie-Eve Beaulieu, Laura Soucek
Cancer Drug Resistance (Alhambra, Calif.)|July 17, 2023
Targeting MYC-driven lymphoma: lessons learned and future directionsSandra Martínez-Martín, Marie-Eve Beaulieu, Laura Soucek
Frontiers in Cell and Developmental Biology|March 21, 2024
MYC: there is more to it than cancerMariano F Zacarías-Fluck, Laura Soucek, Jonathan R Whitfield
Pageof 8

Showing results (11-20 of 71) with videos related to

Sort By:
Pageof 8
Molecular & Cellular Oncology|September 19, 2019
Finding MYCureMarie-Eve Beaulieu, Laura Soucek
Cancer Drug Resistance (Alhambra, Calif.)|May 18, 2022
MYC inhibitors in multiple myelomaSandra Martínez-Martín, Laura Soucek
Cold Spring Harbor Protocols|March 4, 2015
Tamoxifen administration to miceJonathan Whitfield, Trevor Littlewood, Laura Soucek
Cells|April 26, 2020
Structural and Biophysical Insights into the Function of the Intrinsically Disordered Myc OncoproteinMarie-Eve Beaulieu, Francisco Castillo, Laura Soucek
Oncoscience|August 5, 2016
Ibrutinib repurposing: from B-cell malignancies to solid tumorsDaniel Massó-Vallés, Toni Jauset, Laura Soucek
Translational Lung Cancer Research|January 11, 2024
eIF4A dependency: the hidden key to unlock KRAS mutant non-small cell lung cancer's vulnerabilitySilvia Casacuberta-Serra, Iñigo Gonzalez-Larreategui, Laura Soucek
Frontiers in Cell and Developmental Biology|March 11, 2017
Strategies to Inhibit Myc and Their Clinical ApplicabilityJonathan R Whitfield, Marie-Eve Beaulieu, Laura Soucek
Expert Opinion on Therapeutic Targets|February 1, 2020
MYC, MYCL, and MYCN as therapeutic targets in lung cancerDaniel Massó-Vallés, Marie-Eve Beaulieu, Laura Soucek
Cancer Drug Resistance (Alhambra, Calif.)|July 17, 2023
Targeting MYC-driven lymphoma: lessons learned and future directionsSandra Martínez-Martín, Marie-Eve Beaulieu, Laura Soucek
Frontiers in Cell and Developmental Biology|March 21, 2024
MYC: there is more to it than cancerMariano F Zacarías-Fluck, Laura Soucek, Jonathan R Whitfield
Pageof 8